Status:
WITHDRAWN
Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia
Lead Sponsor:
AstraZeneca
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of the study is to determine whether an Internet based compliance tool is superior to common diet counselling in patients with hypercholesterolemia.
Eligibility Criteria
Inclusion
- Available personal mailbox and access to the Internet
- Primary hypercholesterolemia with CV risk \> 20% over 10 years judged by the investigator or a history of ischemic heart disease or other established atherosclerotic disease (claudicatio intermittens, apoplexia cerebri (ischaemic stroke)) or stable diabetes mellitus
- Fasting LDL-C level \> 3.2 mmol/L
Exclusion
- Known heterozygous or homozygous familial hypercholesterolemia or known type III hyperlipoproteinaemia (familial dysbetalipoproteinaemia)
- Documented secondary hypercholesterolemia of any cause except stable diabetes mellitus (type 1 or type 2)
- History of serious adverse effect or hypersensitivity reactions to statins, in particular any history of myopathy
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
1175 Patients enrolled
Trial Details
Trial ID
NCT00240357
Start Date
February 1 2003
Last Update
March 26 2009
Active Locations (109)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aabenraa, Denmark
2
Research Site
Aalborg, Denmark
3
Research Site
Aarhus C, Denmark
4
Research Site
Aerup, Denmark